Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dessintey's medical devices have been adopted by over a hundred hospitals in France and distributed in about fifteen European countries. Clinical adoption has led to a significant increase in access to mirror therapy for stroke patients—from around 10–20% before their devices to approximately 90% today. The company’s solutions are supported by therapists and the scientific community, with positive feedback from early adopters internationally. Their technologies leverage neuroplasticity through immersive digital mirror therapy, with clinical programs typically lasting four to six weeks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dessintey.